Concepedia

Shashi Jatiani

SJ

8

Publications

474

Citations

8

H-Index

2004

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Onconova Therapeutics (United States)

Temple University

Tata Institute of Fundamental Research

Shashi Jatiani is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2020

8

Publications

8

JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies

Shashi Jatiani, Suzanne J. Baker, L.R. Silverman et al. · Genes & Cancer · 2010 · 223 citations · Full text

Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra

Shashi Jatiani, Adolfo Aleman, Deepu Madduri et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 54 citations · Full text

, , +5

SOX11 augments BCR signaling to drive MCL-like tumor development

Pei-Yu Kuo, Shashi Jatiani, Adeeb Rahman et al. · Blood · 2018 · 53 citations · Full text

Dynamin Interacts with Members of the Sumoylation Machinery

Ram Kumar Mishra, Shashi Jatiani, Ashutosh Kumar et al. · Journal of Biological Chemistry · 2004 · 45 citations · Full text

, , +14

A Non-ATP-Competitive Dual Inhibitor of JAK2V617F and BCR-ABLT315I Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition

Shashi Jatiani, Stephen C. Cosenza, M. V. Ramana Reddy et al. · Genes & Cancer · 2010 · 36 citations · Full text

, , +23

Rows per page

1–5 of 8